A Phase 3 study of CBP-307
Latest Information Update: 25 Aug 2020
At a glance
- Drugs Icanbelimod (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Suzhou Connect Biopharmaceuticals
- 25 Aug 2020 New trial record